Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
CN |
|
G
|
Gap Inc
XMUN:GAP
|
US |
|
G
|
Gap Inc
F:GAP
|
US |
|
Y
|
Ypsomed Holding AG
XMUN:OWX
|
CH |
|
L
|
Laboratory Corporation of America Holdings
DUS:LAB
|
US |
|
C
|
CME Group Inc
DUS:MX4A
|
US |
|
P
|
Palo Alto Networks Inc
F:5AP
|
US |
|
Tamburi Investment Partners SpA
MIL:TIP
|
IT |
|
P
|
Pernod Ricard SA
XMUN:PER
|
FR |
|
P
|
Polygiene Group AB
STO:POLYG
|
SE |
|
I
|
Industrial and Commercial Bank of China Ltd
XMUN:ICK
|
CN |
|
Compagnie de Saint Gobain SA
OTC:CODGF
|
FR |
|
L
|
Lithia Motors Inc
XBER:LMO
|
US |
|
Logitech International SA
SIX:LOGN
|
CH |
Wall St Price Targets
Price Targets Summary
Shanghai Pharmaceuticals Holding Co Ltd
According to Wall Street analysts, the average 1-year price target for Shanghai Pharmaceuticals Holding Co Ltd is 21.01 CNY with a low forecast of 12.63 CNY and a high forecast of 27.17 CNY.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Shanghai Pharmaceuticals Holding Co Ltd's stock price target?
Price Target
21.01
CNY
According to Wall Street analysts, the average 1-year price target for Shanghai Pharmaceuticals Holding Co Ltd is 21.01 CNY with a low forecast of 12.63 CNY and a high forecast of 27.17 CNY.
What is the Revenue forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 7%.
What is the Gross Profit forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 3 years is 12%.
What is the Pre-Tax Income forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 9%. The projected CAGR for the next 3 years is 5%.
What is the Net Income forecast for Shanghai Pharmaceuticals Holding Co Ltd?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 3 years is 5%.
